Cargando…

Dose‐escalated simultaneously integrated boost radiation protocol fails to result in a survival advantage for sinonasal tumors in dogs

The prognosis for canine sinonasal tumors remains rather poor despite definitive‐intent radiotherapy (RT). Theoretical calculations predicted improved outcomes with simultaneously integrated boost (SIB) protocols. With the hypothesis of clinically detectable differences in outcome between groups, ou...

Descripción completa

Detalles Bibliográficos
Autores principales:	Meier, Valeria, Staudinger, Chris, Körner, Maximilian, Soukup, Alena, Rohrer Bley, Carla
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Radiation Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9790663/ https://www.ncbi.nlm.nih.gov/pubmed/35347801 http://dx.doi.org/10.1111/vru.13086

Ejemplares similares

Treatment of intracranial neoplasia in dogs using higher doses: A randomized controlled trial comparing a boosted to a conventional radiation protocol
por: Staudinger, Chris, et al.
Publicado: (2022)

Using biologically based objectives to optimize boost intensity‐modulated radiation therapy planning for brainstem tumors in dogs
por: Meier, Valeria, et al.
Publicado: (2019)

Can volumetric modulated arc radiation therapy reduce organ at risk dose in stage 4 sinonasal tumors in dogs treated with boost irradiation?
por: Meier, Valeria, et al.
Publicado: (2021)

Ocular and periocular radiation toxicity in dogs treated for sinonasal tumors: A critical review
por: Wolf, Friederike, et al.
Publicado: (2020)

Relative tumor volume has prognostic relevance in canine sinonasal tumors treated with radiation therapy: A retrospective study
por: Czichon, Felicitas, et al.
Publicado: (2022)

Comparative evaluation of a novel, moderately hypofractionated radiation protocol in 56 dogs with symptomatic intracranial neoplasia
por: Schwarz, Philip, et al.
Publicado: (2018)

Diagnosis and radiation therapy of an extensive myxoma in the retropharyngeal region infiltrating the cranial cervical vertebral canal in a dog
por: Schmid, David, et al.
Publicado: (2022)

Reducing margins for abdominopelvic tumours in dogs: Impact on dose‐coverage and normal tissue complication probability
por: Meier, Valeria, et al.
Publicado: (2021)

A shortened whole brain radiation therapy protocol for meningoencephalitis of unknown origin in dogs
por: Herzig, Robert, et al.
Publicado: (2023)

Letter regarding “Clinical features, diagnosis, and survival analysis of dogs with glioma”
por: Rohrer Bley, Carla, et al.
Publicado: (2022)

Partially ablative radiotherapy (PAR) for large mass tumors using simultaneous integrated boost: A dose‐escalation feasibility study
por: Cilla, Savino, et al.
Publicado: (2018)

Estimation of planning organ at risk volumes for ocular structures in dogs undergoing three‐dimensional image‐guided periocular radiotherapy with rigid bite block immobilization
por: Wolf, Friederike, et al.
Publicado: (2021)

Dose escalation in oropharyngeal cancer: a comparison of simultaneous integrated boost and brachytherapy boost
por: Embring, Anna, et al.
Publicado: (2023)

DNA damage response and DNA repair – dog as a model?
por: Grosse, Nicole, et al.
Publicado: (2014)

A RapidArc planning strategy for prostate with simultaneous integrated boost
por: Jolly, David, et al.
Publicado: (2010)

The Synergistic Effect of Immune Checkpoint Blockade and Radiotherapy in Recurrent/Metastatic Sinonasal Cancer
por: Yazici, Gozde, et al.
Publicado: (2018)

Sinonasal Undifferentiated Carcinoma with Failed Response to Induction Chemotherapy
por: Papazian, Michael R., et al.
Publicado: (2022)

An Open‐label Phase 1 Dose‐escalation Clinical Trial of a Single Intravenous Administration of Gemcitabine in Dogs with Advanced Solid Tumors
por: Marconato, L., et al.
Publicado: (2015)

A Phase II Multi-institutional Clinical Trial Assessing Fractionated Simultaneous In-Field Boost Radiotherapy for Brain Oligometastases
por: Rodrigues, George, et al.
Publicado: (2019)

Simultaneously integrated boost (SIB) spares OAR and reduces treatment time in locally advanced cervical cancer
por: Feng, Christine H., et al.
Publicado: (2016)

A dosimetric evaluation of knowledge‐based VMAT planning with simultaneous integrated boosting for rectal cancer patients
por: Wu, Hao, et al.
Publicado: (2016)

Dose-escalated Radiotherapy with Simultaneous Integrated Boost for Bone Metastases in Selected Patients with Assumed Favourable Prognosis
por: Potkrajcic, Vlatko, et al.
Publicado: (2022)

Definitive Chemoradiation With Dose Escalation for Locally Advanced Gastric Cancer: Case Studies
por: Anthony, Michelle, et al.
Publicado: (2020)

Hypoxia-Related Marker GLUT-1, CAIX, Proliferative Index and Microvessel Density in Canine Oral Malignant Neoplasia
por: Meier, Valeria, et al.
Publicado: (2016)

Retrospective clinical study on outcome in cats with nasal planum squamous cell carcinoma treated with an accelerated radiation protocol
por: Gasymova, Evgeniya, et al.
Publicado: (2017)

Unusual presentation of alveolar echinococcosis as prostatic and paraprostatic cysts in a dog
por: Geigy, Caroline A, et al.
Publicado: (2013)

Megavoltage Radiotherapy for the Treatment of Degenerative Joint Disease in Dogs: Results of a Preliminary Experience in an Italian Radiotherapy Centre
por: Rossi, Federica, et al.
Publicado: (2018)

MRI-guided Dose-escalated Salvage Radiotherapy for Bulky Bladder Neck Recurrence of Prostate Cancer
por: Kishan, Amar U, et al.
Publicado: (2018)

Dosimetric impact of simulated changes in large bowel content during proton therapy with simultaneous integrated boost for locally advanced pancreatic cancer
por: Narita, Yuki, et al.
Publicado: (2021)

A Dosimetric Comparison of Dose Escalation with Simultaneous Integrated Boost for Locally Advanced Non-Small-Cell Lung Cancer
por: Yang, Wenjuan, et al.
Publicado: (2017)

Dose-escalation by hypofractionated simultaneous integrated boost IMRT in unresectable stage III non-small-cell lung cancer
por: Zhang, Qin, et al.
Publicado: (2022)

Simultaneous Integrated Boost for Dose Escalation in Node-Positive Cervical Cancer: 5-Year Experience in a Single Institution
por: Cheung, Elki Sze-Nga, et al.
Publicado: (2023)

Multimodality image fusion in dose escalation studies of brain tumors
por: Rajasekar, D., et al.
Publicado: (2000)

Near‐infrared fluorescent image‐guided lymph node dissection compared with locoregional lymphadenectomies in dogs with mast cell tumours
por: Beer, P., et al.
Publicado: (2022)

Elective nodal irradiation with simultaneous integrated boost stereotactic body radiotherapy for pancreatic cancer: Analyses of planning feasibility and geometrically driven DVH prediction model
por: Nakamura, Akira, et al.
Publicado: (2019)

Dosimetric advantages and clinical outcomes of simultaneous integrated boost intensity-modulated radiotherapy for anal squamous cell carcinoma
por: Sakanaka, Katsuyuki, et al.
Publicado: (2017)

Dose-escalated simultaneously integrated boost photon or proton therapy in pancreatic cancer in an in-silico study: Gastrointestinal organs remain critical
por: Stefanowicz, Sarah, et al.
Publicado: (2020)

Phase I dose-escalation trial of S-1 combined with carbon-ion radiotherapy for sinonasal squamous cell carcinoma
por: Takahashi, Daiki, et al.
Publicado: (2020)

Dosimetric comparison of VitalBeam(®) and Halcyon(TM) 2.0 for hypofractionated VMAT with simultaneous integrated boost treatment of early‐stage left‐sided breast cancer
por: Ju, Eunbin, et al.
Publicado: (2021)

Clinical Experience of Intra-tumoral Central-Dose Escalated Volumetric Modulated Arc Therapy for Lymph Node Metastases in Patients With Advanced Cancer
por: Fujiwara, Masateru, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_m57em1tj7nnubdt9ao0qijk823